Global Animal-Derived Rennin Market Size By Type (Rennin Liquid, Rennin Powder), By Application (Food & Beverage, Pharmaceutical), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal-Derived Rennin Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.78 billion by 2031, expanding at a CAGR of 6.2% during the forecast period from 2023 to 2031. The market is driven by the continued demand for natural coagulants in traditional cheese-making processes, particularly in premium and specialty dairy products. As consumer preference shifts toward artisanal and organic foods, animal-derived rennin—extracted from the stomach lining of calves—continues to find robust applications in the dairy industry despite the growth of microbial and plant-based alternatives.

Drivers:

1. Rising Demand for Artisanal and Specialty Cheese:

With growing consumer interest in authentic and traditional dairy products, the demand for rennin in small-scale and specialty cheese production has surged. Animal-derived rennin is especially preferred for producing high-quality cheese varieties like Parmigiano-Reggiano, Manchego, and Gruyère.

2. Expansion of Dairy Industry in Emerging Economies:

Emerging markets in Asia-Pacific, Latin America, and parts of Africa are witnessing increased dairy consumption. This expansion is creating new avenues for the application of rennin in regional cheese production, especially where traditional cheese-making practices are being preserved.

3. Superior Coagulation Efficiency Compared to Alternatives:

Animal-derived rennin provides superior milk clotting and flavor development compared to microbial or plant-based substitutes, which makes it ideal for high-end dairy production.

Restraints:

1. Ethical and Religious Constraints:

Animal-derived enzymes face ethical concerns among vegetarians and certain religious groups, limiting their application in specific markets. As a result, some dairy producers are transitioning to vegetarian alternatives.

2. Regulatory and Sourcing Challenges:

Obtaining rennin from calves poses both regulatory scrutiny and logistical challenges, especially concerning animal welfare standards and supply chain consistency.

Opportunity:

1. Rising Demand for Premium Dairy Products:

The growing consumer preference for organic and premium dairy is expected to benefit producers using traditional rennin, offering product differentiation and marketing leverage in high-end retail channels.

2. Technological Advancements in Enzyme Purification:

Ongoing innovation in enzyme purification techniques is improving the yield and stability of rennin, allowing producers to extract more efficient enzymes from animal sources while minimizing waste.

3. Niche Market Expansion in Luxury Culinary Segments:

Chefs and gourmet brands are actively seeking high-quality coagulants to enhance flavor profiles, paving the way for rennin's application in exclusive culinary environments.

Market by System Type Insights:

Liquid Rennin held the largest market share in 2023, owing to its ease of mixing and standardized potency. It remains the preferred format in commercial dairy plants due to accurate dosage control and high consistency in enzymatic activity. Powdered Rennin, however, is anticipated to exhibit notable growth due to its extended shelf-life and suitability for artisanal cheese-making environments, particularly in small-scale farms.

Market by End-use Insights:

The Dairy Processing Industry was the dominant end-user segment in 2023, accounting for over 85% of total revenue. Within this, cheese manufacturers represent the primary consumers of animal-derived rennin. Additionally, research institutions and food laboratories form a niche end-user segment utilizing rennin for fermentation and enzyme testing applications.

Market by Regional Insights:

Europe led the market in 2023, supported by its deeply entrenched cheese-making traditions and regulatory acceptance of animal-based rennin in PDO (Protected Designation of Origin) certified products. North America followed, driven by the booming artisan cheese industry in the U.S. Meanwhile, Asia-Pacific is expected to witness the fastest growth due to increasing dairy production in countries like India, China, and Australia.

Competitive Scenario:

Key players in the Global Animal-Derived Rennin Market include Chr. Hansen Holding A/S, Clarion Casein Ltd., Weco International Ltd., DuPont Nutrition & Biosciences, Renco New Zealand, and WalcoRen Ltd. These companies are investing in enzyme optimization, expanding dairy applications, and exploring sustainable sourcing strategies to retain market share.

Key Developments:

2023: Chr. Hansen launched a premium rennin line tailored for artisanal cheese markets in Europe and North America.

2024: Renco New Zealand enhanced its rennin extraction process with green enzyme technology, improving efficiency and reducing environmental footprint.

2025: DuPont expanded its dairy enzyme R&D capabilities to explore hybrid enzyme blends combining animal and microbial rennet for tailored applications.

Scope of Work – Global Animal-Derived Rennin Market

FAQs:

1. What is the current market size of the Global Animal-Derived Rennin Market?

The market was valued at USD 1.1 billion in 2023.

2. What is the major growth driver of the Global Animal-Derived Rennin Market?

The key driver is the rising demand for artisanal and premium cheese that requires traditional coagulants.

3. Which is the largest region during the forecast period in the Global Animal-Derived Rennin Market?

Europe leads the market, supported by its traditional cheese-making heritage and high demand for PDO-certified products.

4. Which segment accounted for the largest market share in the Global Animal-Derived Rennin Market?

The Liquid Rennin segment held the largest share in 2023 due to its widespread use in industrial dairy operations.

5. Who are the key market players in the Global Animal-Derived Rennin Market?

Key players include Chr. Hansen Holding A/S, Renco New Zealand, DuPont Nutrition & Biosciences, WalcoRen Ltd., and Clarion Casein Ltd.